Perioperative biology in primary breast cancer : selective targeting of vasopressin type 2 receptor using desmopressin as a novel therapeutic approach
| Errataetall: |
CommentOn: Breast Cancer Res Treat. 2016 Apr;156(3):411-413. - PMID 27013472 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:158 |
|---|---|
| Enthalten in: |
Breast cancer research and treatment - 158(2016), 3 vom: 08. Aug., Seite 597-9 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Garona, Juan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Comment |
|---|
| Anmerkungen: |
Date Completed 11.12.2017 Date Revised 02.12.2018 published: Print-Electronic CommentOn: Breast Cancer Res Treat. 2016 Apr;156(3):411-413. - PMID 27013472 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10549-016-3899-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM262208865 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM262208865 | ||
| 003 | DE-627 | ||
| 005 | 20231224201245.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10549-016-3899-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0874.xml |
| 035 | |a (DE-627)NLM262208865 | ||
| 035 | |a (NLM)27393620 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Garona, Juan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Perioperative biology in primary breast cancer |b selective targeting of vasopressin type 2 receptor using desmopressin as a novel therapeutic approach |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.12.2017 | ||
| 500 | |a Date Revised 02.12.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Breast Cancer Res Treat. 2016 Apr;156(3):411-413. - PMID 27013472 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Receptors, Vasopressin |2 NLM | |
| 650 | 7 | |a Deamino Arginine Vasopressin |2 NLM | |
| 650 | 7 | |a ENR1LLB0FP |2 NLM | |
| 700 | 1 | |a Alonso, Daniel F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Breast cancer research and treatment |d 1992 |g 158(2016), 3 vom: 08. Aug., Seite 597-9 |w (DE-627)NLM01302132X |x 1573-7217 |7 nnns |
| 773 | 1 | 8 | |g volume:158 |g year:2016 |g number:3 |g day:08 |g month:08 |g pages:597-9 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10549-016-3899-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 158 |j 2016 |e 3 |b 08 |c 08 |h 597-9 | ||